USPTO serial 79222695
R&D BIONICE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SAUNDERS, ANDREA DAWN
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with R&D BIONICE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism; pharmaceutical and veterinary active ingredients for treating diseases of the cardiovascular system; pharmaceutical and veterinary active ingredients for treatment of diseases of the skin; pharmaceutical and veterinary active ingredients for treatment of diseases of the respiratory system; pharmaceutical and veterinary active ingredients for treating diseases of the musculoskeletal system; pharmaceutical and veterinary active ingredients for treating diseases of the nervous system; pharmaceutical preparations, namely, antidepressants; sanitary products for medical use; dietetic food and substances for medical or veterinary use; disinfectants; products for destroying vermin; fungicides, herbicides; chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; hormones for medical use; steroids; antihistamines | ACTIVE | — |
| 040 | Custom manufacture of pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism, diseases of the cardiovascular system, diseases of the skin, diseases of the respiratory system, diseases of the musculoskeletal system and diseases of the nervous system; custom manufacture of chemico-pharmaceutical preparations, namely, antidepressants; custom manufacture of sanitary products for medical use; custom manufacture of dietetic food and substances for medical or veterinary use; custom manufacture of disinfectants, products for destroying vermin, fungicides and herbicides; custom manufacture of chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; custom manufacture of hormones for medical use, steroids and antihistamines; processing of pharmaceutical and chemical products | ACTIVE | — |
| 042 | Pharmaceutical research and development; providing medical research information; providing veterinary research information; conducting clinical trials for others relating to pharmaceutical products; laboratory services, namely, analytical laboratory services; analysis and evaluation of product development; design and development of new technology for others in the field of biotechnology, pharmacy and chemistry; provision of information, advice and consultancy relating to all the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CURIA SPAIN, S.A.U.
- Other trademarks owned by CRYSTAL PHARMA, S.A.U.
- Other trademarks owned by BIONICE, S.L.U.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named R&D BIONICE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 5, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 12, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 23, 2019 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 6, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 6, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 23, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 8, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 8, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 6, 2018 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 6, 2018 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 27, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 6, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 6, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 16, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 7, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |